Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI)
TETRAPH PHARMA (NASDAQ: TTPH) Delayed: 2.20 --0 (-0%)
Previous Close $2.20    52 Week High $12.45 
Open $17.31    52 Week Low $3.11 
Day High $2.20    P/E N/A 
Day Low $2.20    EPS $-2.70 
Volume 105,485